Evidence map›Paper›PMID 40941013›Full record

ArticleCancers2025

A Comparative Study of Quality of Life and Oncologic Outcomes in Premenopausal Women with Hormone Receptor-Positive Breast Cancer: Bilateral Oophorectomy vs. Gonadotropin-Releasing Hormone Agonist Therapy.

Evrim Erdemoglu, Kathryn J Ruddy, Matthew R Buras, Jaxon Quillen, Fergus J Couch, Janet E Olson, Laura M Bozzuto, Nicole L Larson, Johnny Yi, Kristina A Butler

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Evrim ErdemogluDepartment of Medical and Surgical Gynecology, Mayo Clinic, Phoenix, AZ 85054, USA.ORCID 0000-0002-5993-6968
Kathryn J RuddyDepartment of Oncology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-6298-332X
Matthew R BurasDivision of Clinical Trials and Biostatistics Quantitative Health Science Research, Mayo Clinic, Arizona, MN 55905, USA.ORCID 0000-0001-6503-0989
Jaxon QuillenDivision of Clinical Trials and Biostatistics Quantitative Health Science Research, Mayo Clinic, Arizona, MN 55905, USA.ORCID 0000-0001-7595-7630
Fergus J CouchDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Janet E OlsonDepartment of Quantitative Health Science, Mayo Clinic, Rochester, MN 55905, USA.
Laura M BozzutoDivision of Surgical Oncology, Department of Surgery, Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
Nicole L LarsonDepartment of Quantitative Health Science, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-2129-6934
Johnny YiDepartment of Medical and Surgical Gynecology, Mayo Clinic, Phoenix, AZ 85054, USA.
Kristina A ButlerDepartment of Medical and Surgical Gynecology, Mayo Clinic, Phoenix, AZ 85054, USA.

Funding

The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2005 to 2026
$49.9M
Resolving the cancer relevance of predisposition gene mutationsR35CA253187 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2020 to 2026
$5.8M
NCI NIH HHS P50 CA116201NCI NIH HHS R35 CA253187
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerGnRHgonadotropin-releasing hormoneoophorectomyovarian function suppressionpatient-reported outcomesPROMIS-10quality of life

Identifiers

PMID40941013
PMCPMC12427670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.